Clinical Trials
2 trialsNCT07551479 2026-04-24
TORCH-STAR
Fudan University
Phase 3 Not yet recruiting
NCT06835179 2025-02-19
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting